Bharat Immunologicals P/B Ratio

Current P/B Ratio
-2.22
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity

Bharat Immunologicals (BIBCL) P/B ratio is -2.22 (Low), book value per share ₹20.47 vs Healthcare average P/B of -0.24 — Very Low - Significant discount to book value, potential distress or value opportunity. For live price, earnings yield and the full fundamental profile, see Bharat Immunologicals share price screener.

Current Valuation Metrics

P/B Ratio -2.22
Current Price ₹15.86
Book Value/Share ₹20.47
Exchange BSE

Book Value Breakdown (2023)

Balance Sheet Components
Total Equity ₹88 Cr
Share Capital ₹43 Cr
Reserves & Surplus ₹45 Cr
Outstanding Shares 43,000,000
Book Value per Share ₹20.47

Valuation Signal

Signal Undervalued
Historical Avg 4.43
Historical Range 1.02 - 10.4
Percentile 0.0%

Sector Context

Sector Average -0.24
Sector Median 0.6
Sector Rank #7 of 50
Sector Percentile 14.0%

BIBCL P/B Ratio — Valuation Insights & Book Value Analysis

Bharat Immunologicals price-to-book ratio interpretation, valuation status and historical context — current P/B -2.22 (Low). View BIBCL annual price range for the annual high/low range and current price position.

  • Stock appears undervalued with PB of -2.22, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Current PB is 150.1% below historical average
  • Trading at discount to sector average PB of -0.24

Bharat Immunologicals P/B Ratio Historical Trend

BIBCL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review BIBCL earnings multiple to evaluate earnings-based valuation against sector peers.

BIBCL Historical P/B Ratio — Book Value Per Share & Year-End Price

Bharat Immunologicals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2023 1.73 ₹20.47 ₹35.35 ₹88 Moderate
2022 1.63 ₹24.42 ₹39.90 ₹105 Moderate
2021 7.39 ₹7.91 ₹58.45 ₹34 High
2020 10.4 ₹4.88 ₹50.80 ₹21 High
2019 1.02 ₹7.21 ₹7.38 ₹31 Moderate

BIBCL vs Healthcare Peers — P/B Ratio Comparison

Bharat Immunologicals P/B -2.22 vs Healthcare average -0.24, median 0.6 — range -14.47–1.1.

Sector Average
-0.24
Sector Median
0.6
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -14.47 ₹18 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹115 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.5 ₹44 Low
Triochem Products TRIPR 0.04 ₹0 Low